PatientsVille.com Logo

Petit mal epilepsy and Epilim

PatientsVille

Petit Mal Epilepsy Symptoms and Causes

Seizures are symptoms of a brain problem. They happen because of sudden, abnormal electrical activity in the brain. When people think of seizures, they often think of convulsions in which a person's body shakes rapidly and uncontrollably. Not all seizures cause convulsions. There are many types of seizures and some have mild symptoms. Seizures fall into two main groups. Focal seizures, also called partial seizures, happen in just one part of the brain. Generalized seizures are a result of abnormal activity on both sides of the brain.

Most seizures last from 30 seconds to 2 minutes and do not cause lasting harm. However, it is a medical emergency if seizures last longer than 5 minutes or if a person has many seizures and does not wake up between them. Seizures can have many causes, including medicines, high fevers, head injuries and certain diseases. People who have recurring seizures due to a brain disorder have epilepsy.

NIH: National Institute of Neurological Disorders and Stroke

Check out the latest treatments for petit mal epilepsy

petit mal epilepsy treatment research studies

Epilim clinical trials, surveys and public health registries


Find Drug Side Effect reports



Epilim Side Effects

Convulsion (118)
Epilepsy (44)
Tremor (23)
Abnormal Behaviour (22)
Somnolence (18)
Confusional State (17)
Dizziness (16)
Fatigue (15)
Aggression (15)
Fall (15)
Malaise (13)
Asthenia (12)
Headache (12)
Coordination Abnormal (12)
Petit Mal Epilepsy (12)
Nausea (12)
Product Quality Issue (11)
Weight Increased (11)
Developmental Delay (9)
Off Label Use (9)
Intentional Overdose (8)
Coma (8)
Grand Mal Convulsion (8)
Hyponatraemia (8)
Overdose (8)
Weight Decreased (8)
Pyrexia (8)
Congenital Nose Malformation (7)
Amnesia (7)
Depression (7)
Disturbance In Attention (7)
Rash (7)
Loss Of Consciousness (7)
Pruritus (7)
Foetal Valproate Syndrome (7)
Cyanosis (6)
Accidental Overdose (6)
Gait Disturbance (6)
Abdominal Distension (6)
Suicide Attempt (6)
Product Substitution Issue (6)
Vision Blurred (6)
Speech Disorder (6)
Myoclonus (5)
Neutropenia (5)
Mental Disorder (5)
Influenza Like Illness (5)
Hypotension (5)
Lethargy (5)
Liver Function Test Abnormal (5)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I been on this six wks now& can't stop sleeping &have been getting itchy burning eyes

Been on this 14 monthstoo long comming off it thank god to many problems on epilim to name, i only had 1 seizure in my life at 28 and i was apparently anepilepticthey put me on tretegol after i was refered to see a neuro

Been reading posts - my eplium has just been doubled because of bi-polar symptoms .. reading posts and think it would be easier to live life a little crazy - nice to hear some hope. Thanks.

Boy 7 years became very hyperactive. He was already on colouring free diet and we wondered if the bright red colouring couls have caused the behavioural change. Also came out in spots and was, and still is very tired. Has an increased appetite.

Can cipramil and epilim be taken together?

Can you please tell me the side effects of Epilim 200 mg? My daughter is 4 and half year age. She is taking the medicine by consulting the Pediatics and child Neorologist. We are observing our daughter that she feels pain in her toe (Leg finger) and

Discribe you eplim experiance here

Does epilim cause speach loss

Epilim is used for a mood stabaliser as well as a anti convulsant, so it may help with the anxiety, it can make some people tired, i am always tired! but still work, drive etc.....all the best.

Epilum - I have been treated for epilepsy from the age of 14, I am now 34. I have had only 3 episodes in my life. I have used convulex which worked very well. Dr switched me to rivitrol when I wanted to get pregnant.&

is epilepsy is life long?????

66 yearr old male living in Winnipeg, MB Cannada. Ialso have other medical problems besides this one. Like Epilepsy, Antidepressant,Migraines,Chloresterol,Klinefelter's Syndrome,High blood pressure, Shortness of breath, HIV, ITCHING.

Alternative to Lofepramine, bearing in mind that patient has epilepsy

Docetaxel and Lamictal cause vertigo after first Lamictal pill in a.m., even tho I'm a couple of weeks since last infusion. Taxotere for advanced prostate cancer; Lamictal for epilepsy. Neurologist doesn't want to lower Lamictal dose; I'm on a trial

Epilum - I have been treated for epilepsy from the age of 14, I am now 34. I have had only 3 episodes in my life. I have used convulex which worked very well. Dr switched me to rivitrol when I wanted to get pregnant.&

G'day all. Have tried other products, have seen epilepsy induced by another quitting drug in a patient taking Sodium Valproate as mood stabilizer. Wondering if any reactions like this have been observed. Also, any info on reactions with Seroquel or o

Hi my Mom is 78yo and had her first seizure 5mths ago (we think due to the flu vaccine)and another 4wks ago, she was diagnosed with Epilepsy after her second episodeand put on Epilim. Since then she has deteriorated sign

Hi, I was diagnosed with Epilepsy about 2 months ago after small misdiagnosed seizures evolved into 'Grand Mal' seizures. I have been taking 300mg Epanutin per day (3x100mg capsules), and so far have had no further seizures, small or large. My

I am new to taking medicine for epilepsy, but i have had all of my life, but i can tell you that keppra was the worst medicine. I cried all the time, suicidal, and anxious. but icame completely off of keppra and swithched to lamictal alone and i stil

I am now 37 and have been on epilim for the past 19 years. I stuggle alot with my weight and have even considered a gastric bypass but after doing some research found out that people who suffered from epilepsy who had the operatin only got worse so d

Petit Mal Epilepsy Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets
Condition: Epilepsy
Interventions: Drug: Divalproex Sodium Extended-release 250mg;   Drug: DEPAKOTE 250mg
Outcome Measure: Evaluate generic divalproex sodium extended release to Depakote ER
2 Recruiting Valproic Acid for the Prevention of Post-Amputation Pain
Conditions: Pain, Phantom;   Pain, Neuropathic
Interventions: Drug: Valproic Acid;   Other: Cherry Syrup
Outcome Measures: Efficacy of Valproic Acid in reducing the Incidence of chronic neuropathic and post-amputation pain.;   Neuropathic limb or post-amputation pain, and the incidence of pain sub-types;   Effect on analgesic requirement;   Qualitative characterization of pain sub-types
3 Recruiting Bevacizumab, Temsirolimus, Valproic Acid, Cetuximab
Condition: Advanced Cancers
Interventions: Drug: Temsirolimus;   Drug: Bevacizumab;   Drug: Valproic Acid;   Drug: Cetuximab
Outcome Measures: Maximum Tolerated Dose (MTD) of Bevacizumab and Temsirolimus and/or Cetuximab or Valproic Acid;   Tumor Response
4 Recruiting Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot
Condition: Cancer
Intervention: Drug: Valproic Acid
Outcome Measures: Determine if valproic acid levels correlate with histone acetylation in leukocytes during treatment and whether either valproic acid levels or histone acetylation in leukocytes predict histone acetylation in tumor samples post treatment.;   Assess the sensitivity and specificity of the genomic sensitivity signature of VPA (GDSS-VPA) to predict histologically measured antitumor activity of valproic acid in newly diagnosed breast cancer.;   Analyze the change in immunohistochemical markers of proliferation, apoptosis, and tumor grade following treatment with valproic acid in newly diagnosed breast cancer.;   Analyze the change in radiologic markers of tumor size and vascularity following treatment with valproic acid in newly diagnosed breast cancer;   Analyze whether intrinsic breast subtype by the Breast Bioclassifier correlates with changes in tumor proliferation rate or changes in DCE-MRI markers of size and vascularity following treatment with valproic acid.;   Determine if women have dose-limiting toxicities for valproic acid over 7-12 days
5 Unknown  Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Valproic acid
Outcome Measures: Best clinical response as defined by NCIWG criteria for CLL;   Hematological toxicity (graded according to NCIWG criteria for CLL);   Non- hematological toxicity (graded according to NCI common toxicity criteria)
6 Recruiting Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Interventions: Drug: Valproate, Levocarnitine;   Drug: Placebo
Outcome Measures: Change in muscle power on a 5 point scale as per the principles of manual muscle testing at 12, 24, 36 and 52 weeks;   a) Change in functional measure using modified Hammersmith Functional Motor Scale (MHFMS) score at 12, 24, 36 and 52 weeks 12, 24, 36 and 52 weeks.
7 Not yet recruiting Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.
Conditions: Generalized Convulsive Status Epilepticus;   Intensive Care Unit
Interventions: Drug: Intravenous Sodium Valproate;   Drug: Placebo
Outcome Measures: Number of patients in ICU for a GCSE discharged alive from the hospital at Day 15.;   Frequency of refractory status epilepticus;   Morbidity related to ICU stay;   Cognitive dysfunction
8 Not yet recruiting Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma
Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Iris Melanoma;   Stage I Intraocular Melanoma;   Stage IIA Intraocular Melanoma;   Stage IIB Intraocular Melanoma;   Stage IIIA Intraocular Melanoma;   Stage IIIB Intraocular Melanoma;   Stage IIIC Intraocular Melanoma
Interventions: Drug: Sunitinib;   Drug: Valproic Acid
Outcome Measures: Overall survival;   Relapse-free survival;   Tolerability
9 Recruiting Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
Conditions: Hematuria;   Bladder Cancer
Intervention: Drug: Valproic Acid
Outcome Measures: Thrombospondin-1 gene expression;   Angiogenesis, proliferation, and histone deacetylase activity markers
10 Recruiting A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Condition: Thyroid Neoplasm
Intervention: Drug: Valproic Acid
Outcome Measures: To determine if valproic acid will inhibit thyroid cancer growth, as evidenced by a decrease in thyroglobulin level, and tumor size.;   To determine if valproic acid therapy will induce differentiation of and therefore increase uptake of radioactive iodine by the tumor cells. To determine the effect of valproic acid on differentiation markers.
11 Unknown  Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment
Conditions: Epilepsy;   Adverse Effects
Interventions: Drug: valproate sodium;   Genetic: Polymorphism Analysis;   Other: Pharmacokinetic analysis
Outcome Measure: epileptic seizure
12 Not yet recruiting Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium
Condition: Autism
Interventions: Drug: divalproex sodium;   Other: Placebo
Outcome Measures: effect of drug vs placebo on reduction in epileptiform EEG discharges in children with ASD;   behavior changes in drug vs placebo.
13 Recruiting Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Conditions: Acute Myelogenous Leukemia AML;   Myelodysplastic Syndrome MDS
Intervention: Drug: Vidaza and Valproic Acid
Outcome Measures: Survival;   Disease Relapse
14 Recruiting Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
Conditions: Sarcoma;   Soft Tissue Sarcoma;   Locally Advanced Sarcoma;   Unresectable Sarcoma;   Metastatic Sarcoma
Intervention: Drug: Bevacizumab, Gemcitabine, docetaxel and valproic acid
Outcome Measure: Dose-limiting toxicities per CTCAE 4.0; grade 4 hematologic toxicity; grade 3 or 4 hepatotoxicity.
15 Recruiting A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers or Trauma Patients
Conditions: Healthy Individuals Safety Study;   Shock,Hemorrhagic
Interventions: Drug: Valproic Acid;   Drug: Isotonic saline solution
Outcome Measure: Dose limiting toxicity (DLT)
16 Recruiting Trial of Oral Valproic Acid for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Valproic Acid;   Drug: Placebo
Outcome Measures: Mean change in visual field area from baseline to 52 weeks.;   Static perimetry measurements in the full visual field;   Mean change in best corrected visual acuity.;   Color contrast sensitivity;   Mean change in peak Electroretinogram (ERG) amplitude;   Mean change in central macular thickness and macular volume;   Change in fundus appearance;   Mean change in total score on vision-related quality of life.;   Changes in clinical laboratory data;   Changes in physical examination findings
17 Recruiting Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: Valproate;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone
Outcome Measure: Establishment of maximum tolerable dose of valproate.
18 Not yet recruiting Valproic Acid (VPA) vs Placebo
Condition: Breast Cancer
Interventions: Drug: Placebo;   Drug: Valproic Acid (VPA);   Behavioral: Questionnaires;   Behavioral: Pill Diary;   Behavioral: Drainage Diary
Outcome Measure: Time to Pleural Catheter Removal
19 Recruiting Traumatic Neuroprotection and Epilepsy Prevention of Valproate Acid
Condition: Traumatic Brain Injury
Intervention: Drug: valproate acid
Outcome Measures: DRS scores;   the time of break out and state of epilepsy;   brain MRI scan;   the blood concentration of VPA
20 Unknown  Hydralazine Valproate for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Hydralazine and magnesium valproate;   Drug: Placebo
Outcome Measures: Progression-Free Survival;   Safety, response, overall survival.